Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Non-Current Debt: 2014-2025

Historic Non-Current Debt for BIO-TECHNE (TECH) over the last 12 years, with Jun 2025 value amounting to $346.0 million.

  • BIO-TECHNE's Non-Current Debt changed negligibly% to $300.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $300.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $346.0 million for FY2025, which is 8.46% up from last year.
  • Per BIO-TECHNE's latest filing, its Non-Current Debt stood at $346.0 million for FY2025, which was up 8.46% from $319.0 million recorded in FY2024.
  • In the past 5 years, BIO-TECHNE's Non-Current Debt ranged from a high of $350.0 million in FY2023 and a low of $243.4 million during FY2022.
  • Over the past 3 years, BIO-TECHNE's median Non-Current Debt value was $346.0 million (recorded in 2025), while the average stood at $338.3 million.
  • Per our database at Business Quant, BIO-TECHNE's Non-Current Debt fell by 25.98% in 2022 and then soared by 43.79% in 2023.
  • Over the past 5 years, BIO-TECHNE's Non-Current Debt (Yearly) stood at $328.8 million in 2021, then fell by 25.98% to $243.4 million in 2022, then soared by 43.79% to $350.0 million in 2023, then decreased by 8.86% to $319.0 million in 2024, then grew by 8.46% to $346.0 million in 2025.